Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1876007

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1876007

Non-invasive Glucose Monitoring Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED:
PAGES: 122 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multi User License)
USD 5925
PDF (Enterprise User License)
USD 7900

Add to Cart

The global market for Non-invasive Glucose Monitoring Device was estimated to be worth US$ 12256 million in 2024 and is forecast to a readjusted size of US$ 31463 million by 2031 with a CAGR of 14.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Non-invasive Glucose Monitoring Device cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Non-invasive glucose monitoring device could measure your glucose without hurt your finger. Non-invasive glucose monitoring device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.In this report, we study both disposable sensors and durable systems.

The non-invasive glucose monitoring device market is gaining momentum due to the rising global prevalence of diabetes and the growing demand for painless, convenient, and continuous blood glucose tracking. Traditional finger-prick methods can be uncomfortable and are often associated with poor patient compliance, especially among children, the elderly, and individuals with type 1 or type 2 diabetes who require frequent monitoring. Non-invasive devices-using technologies such as optical sensors, spectroscopy, or radio waves-offer a promising alternative by enabling real-time glucose measurements without the need for blood samples. Increasing health awareness, a shift toward preventive care, and the integration of wearable health technologies (e.g., smartwatches with glucose monitoring capabilities) are further fueling market growth. Additionally, ongoing investments from both medical device companies and tech giants, along with favorable regulatory support in certain regions, are accelerating product development and commercialization.

Despite these opportunities, the non-invasive glucose monitoring market faces several significant challenges. The primary hurdle is technological: achieving consistently accurate and reliable readings without drawing blood remains a complex problem. Many non-invasive devices still struggle with calibration issues, measurement delays, and variability due to external factors like skin tone, temperature, or hydration levels. Regulatory approval processes for these devices are also rigorous, given the potential risks of inaccurate glucose data leading to improper treatment decisions. Moreover, the high cost of advanced non-invasive technologies may hinder adoption, especially in price-sensitive or low-income markets. Skepticism among clinicians and patients due to inconsistent performance in earlier generations of devices also poses a trust barrier. To overcome these challenges, manufacturers must prioritize clinical validation, user-centered design, and collaboration with regulatory agencies to ensure safety, accuracy, and usability of next-generation non-invasive glucose monitors.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Glucose Monitoring Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-invasive Glucose Monitoring Device by region & country, by Type, and by Application.

The Non-invasive Glucose Monitoring Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Glucose Monitoring Device.

Market Segmentation

By Company

  • Abbott
  • DexCom
  • Medtronic
  • Senseonics Holdings
  • Cnoga Medical
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical
  • POCTech
  • SIBIONICS
  • GHA Life
  • Infinovo Medical

Segment by Type

  • Wearable Devices
  • Non-wearable Devices

Segment by Application

  • Hospital
  • Home Care
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Non-invasive Glucose Monitoring Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Non-invasive Glucose Monitoring Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Non-invasive Glucose Monitoring Device in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Non-invasive Glucose Monitoring Device Product Introduction
  • 1.2 Global Non-invasive Glucose Monitoring Device Market Size Forecast
    • 1.2.1 Global Non-invasive Glucose Monitoring Device Sales Value (2020-2031)
    • 1.2.2 Global Non-invasive Glucose Monitoring Device Sales Volume (2020-2031)
    • 1.2.3 Global Non-invasive Glucose Monitoring Device Sales Price (2020-2031)
  • 1.3 Non-invasive Glucose Monitoring Device Market Trends & Drivers
    • 1.3.1 Non-invasive Glucose Monitoring Device Industry Trends
    • 1.3.2 Non-invasive Glucose Monitoring Device Market Drivers & Opportunity
    • 1.3.3 Non-invasive Glucose Monitoring Device Market Challenges
    • 1.3.4 Non-invasive Glucose Monitoring Device Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Non-invasive Glucose Monitoring Device Players Revenue Ranking (2024)
  • 2.2 Global Non-invasive Glucose Monitoring Device Revenue by Company (2020-2025)
  • 2.3 Global Non-invasive Glucose Monitoring Device Players Sales Volume Ranking (2024)
  • 2.4 Global Non-invasive Glucose Monitoring Device Sales Volume by Company Players (2020-2025)
  • 2.5 Global Non-invasive Glucose Monitoring Device Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Non-invasive Glucose Monitoring Device Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Non-invasive Glucose Monitoring Device Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Non-invasive Glucose Monitoring Device
  • 2.9 Non-invasive Glucose Monitoring Device Market Competitive Analysis
    • 2.9.1 Non-invasive Glucose Monitoring Device Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Non-invasive Glucose Monitoring Device Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Glucose Monitoring Device as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Wearable Devices
    • 3.1.2 Non-wearable Devices
  • 3.2 Global Non-invasive Glucose Monitoring Device Sales Value by Type
    • 3.2.1 Global Non-invasive Glucose Monitoring Device Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Non-invasive Glucose Monitoring Device Sales Value, by Type (2020-2031)
    • 3.2.3 Global Non-invasive Glucose Monitoring Device Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Type
    • 3.3.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Non-invasive Glucose Monitoring Device Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Non-invasive Glucose Monitoring Device Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Non-invasive Glucose Monitoring Device Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Home Care
    • 4.1.3 Other
  • 4.2 Global Non-invasive Glucose Monitoring Device Sales Value by Application
    • 4.2.1 Global Non-invasive Glucose Monitoring Device Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Non-invasive Glucose Monitoring Device Sales Value, by Application (2020-2031)
    • 4.2.3 Global Non-invasive Glucose Monitoring Device Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Application
    • 4.3.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Non-invasive Glucose Monitoring Device Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Non-invasive Glucose Monitoring Device Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Non-invasive Glucose Monitoring Device Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Non-invasive Glucose Monitoring Device Sales Value by Region
    • 5.1.1 Global Non-invasive Glucose Monitoring Device Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Non-invasive Glucose Monitoring Device Sales Value by Region (2020-2025)
    • 5.1.3 Global Non-invasive Glucose Monitoring Device Sales Value by Region (2026-2031)
    • 5.1.4 Global Non-invasive Glucose Monitoring Device Sales Value by Region (%), (2020-2031)
  • 5.2 Global Non-invasive Glucose Monitoring Device Sales Volume by Region
    • 5.2.1 Global Non-invasive Glucose Monitoring Device Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2020-2025)
    • 5.2.3 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2026-2031)
    • 5.2.4 Global Non-invasive Glucose Monitoring Device Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Non-invasive Glucose Monitoring Device Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 5.4.2 North America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 5.5.2 Europe Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Non-invasive Glucose Monitoring Device Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 5.7.2 South America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.3.2 United States Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.4.2 Europe Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.5.2 China Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.6.2 Japan Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.7.2 South Korea Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Non-invasive Glucose Monitoring Device Sales Value, 2020-2031
    • 6.9.2 India Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Non-invasive Glucose Monitoring Device Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Non-invasive Glucose Monitoring Device Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 DexCom
    • 7.2.1 DexCom Company Information
    • 7.2.2 DexCom Introduction and Business Overview
    • 7.2.3 DexCom Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 DexCom Non-invasive Glucose Monitoring Device Product Offerings
    • 7.2.5 DexCom Recent Development
  • 7.3 Medtronic
    • 7.3.1 Medtronic Company Information
    • 7.3.2 Medtronic Introduction and Business Overview
    • 7.3.3 Medtronic Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medtronic Non-invasive Glucose Monitoring Device Product Offerings
    • 7.3.5 Medtronic Recent Development
  • 7.4 Senseonics Holdings
    • 7.4.1 Senseonics Holdings Company Information
    • 7.4.2 Senseonics Holdings Introduction and Business Overview
    • 7.4.3 Senseonics Holdings Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Senseonics Holdings Non-invasive Glucose Monitoring Device Product Offerings
    • 7.4.5 Senseonics Holdings Recent Development
  • 7.5 Cnoga Medical
    • 7.5.1 Cnoga Medical Company Information
    • 7.5.2 Cnoga Medical Introduction and Business Overview
    • 7.5.3 Cnoga Medical Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cnoga Medical Non-invasive Glucose Monitoring Device Product Offerings
    • 7.5.5 Cnoga Medical Recent Development
  • 7.6 Meiqi Medical
    • 7.6.1 Meiqi Medical Company Information
    • 7.6.2 Meiqi Medical Introduction and Business Overview
    • 7.6.3 Meiqi Medical Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Meiqi Medical Non-invasive Glucose Monitoring Device Product Offerings
    • 7.6.5 Meiqi Medical Recent Development
  • 7.7 Medtrum Technologies
    • 7.7.1 Medtrum Technologies Company Information
    • 7.7.2 Medtrum Technologies Introduction and Business Overview
    • 7.7.3 Medtrum Technologies Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Medtrum Technologies Non-invasive Glucose Monitoring Device Product Offerings
    • 7.7.5 Medtrum Technologies Recent Development
  • 7.8 MicroTech Medical
    • 7.8.1 MicroTech Medical Company Information
    • 7.8.2 MicroTech Medical Introduction and Business Overview
    • 7.8.3 MicroTech Medical Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 MicroTech Medical Non-invasive Glucose Monitoring Device Product Offerings
    • 7.8.5 MicroTech Medical Recent Development
  • 7.9 POCTech
    • 7.9.1 POCTech Company Information
    • 7.9.2 POCTech Introduction and Business Overview
    • 7.9.3 POCTech Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 POCTech Non-invasive Glucose Monitoring Device Product Offerings
    • 7.9.5 POCTech Recent Development
  • 7.10 SIBIONICS
    • 7.10.1 SIBIONICS Company Information
    • 7.10.2 SIBIONICS Introduction and Business Overview
    • 7.10.3 SIBIONICS Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 SIBIONICS Non-invasive Glucose Monitoring Device Product Offerings
    • 7.10.5 SIBIONICS Recent Development
  • 7.11 GHA Life
    • 7.11.1 GHA Life Company Information
    • 7.11.2 GHA Life Introduction and Business Overview
    • 7.11.3 GHA Life Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 GHA Life Non-invasive Glucose Monitoring Device Product Offerings
    • 7.11.5 GHA Life Recent Development
  • 7.12 Infinovo Medical
    • 7.12.1 Infinovo Medical Company Information
    • 7.12.2 Infinovo Medical Introduction and Business Overview
    • 7.12.3 Infinovo Medical Non-invasive Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Infinovo Medical Non-invasive Glucose Monitoring Device Product Offerings
    • 7.12.5 Infinovo Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Non-invasive Glucose Monitoring Device Industrial Chain
  • 8.2 Non-invasive Glucose Monitoring Device Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Non-invasive Glucose Monitoring Device Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Non-invasive Glucose Monitoring Device Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Non-invasive Glucose Monitoring Device Market Trends
  • Table 2. Non-invasive Glucose Monitoring Device Market Drivers & Opportunity
  • Table 3. Non-invasive Glucose Monitoring Device Market Challenges
  • Table 4. Non-invasive Glucose Monitoring Device Market Restraints
  • Table 5. Global Non-invasive Glucose Monitoring Device Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Non-invasive Glucose Monitoring Device Revenue Market Share by Company (2020-2025)
  • Table 7. Global Non-invasive Glucose Monitoring Device Sales Volume by Company (2020-2025) & ()
  • Table 8. Global Non-invasive Glucose Monitoring Device Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Non-invasive Glucose Monitoring Device Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Non-invasive Glucose Monitoring Device Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Non-invasive Glucose Monitoring Device Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Non-invasive Glucose Monitoring Device
  • Table 13. Global Non-invasive Glucose Monitoring Device Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Glucose Monitoring Device as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Non-invasive Glucose Monitoring Device Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Non-invasive Glucose Monitoring Device Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Non-invasive Glucose Monitoring Device Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Non-invasive Glucose Monitoring Device Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Non-invasive Glucose Monitoring Device Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Non-invasive Glucose Monitoring Device Sales Volume by Type: 2020 VS 2024 VS 2031 ()
  • Table 22. Global Non-invasive Glucose Monitoring Device Sales Volume by Type (2020-2025) & ()
  • Table 23. Global Non-invasive Glucose Monitoring Device Sales Volume by Type (2026-2031) & ()
  • Table 24. Global Non-invasive Glucose Monitoring Device Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Non-invasive Glucose Monitoring Device Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Non-invasive Glucose Monitoring Device Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Non-invasive Glucose Monitoring Device Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Non-invasive Glucose Monitoring Device Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Non-invasive Glucose Monitoring Device Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Non-invasive Glucose Monitoring Device Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Non-invasive Glucose Monitoring Device Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Non-invasive Glucose Monitoring Device Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Non-invasive Glucose Monitoring Device Sales Volume by Application: 2020 VS 2024 VS 2031 ()
  • Table 34. Global Non-invasive Glucose Monitoring Device Sales Volume by Application (2020-2025) & ()
  • Table 35. Global Non-invasive Glucose Monitoring Device Sales Volume by Application (2026-2031) & ()
  • Table 36. Global Non-invasive Glucose Monitoring Device Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Non-invasive Glucose Monitoring Device Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Non-invasive Glucose Monitoring Device Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Non-invasive Glucose Monitoring Device Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Non-invasive Glucose Monitoring Device Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Non-invasive Glucose Monitoring Device Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Non-invasive Glucose Monitoring Device Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Non-invasive Glucose Monitoring Device Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Non-invasive Glucose Monitoring Device Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Non-invasive Glucose Monitoring Device Sales Volume by Region (): 2020 VS 2024 VS 2031
  • Table 46. Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2020-2025) & ()
  • Table 47. Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2026-2031) & ()
  • Table 48. Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Non-invasive Glucose Monitoring Device Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Non-invasive Glucose Monitoring Device Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Non-invasive Glucose Monitoring Device Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Volume, (2020-2025) & ()
  • Table 56. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Volume, (2026-2031) & ()
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Non-invasive Glucose Monitoring Device Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. DexCom Company Information
  • Table 63. DexCom Introduction and Business Overview
  • Table 64. DexCom Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. DexCom Non-invasive Glucose Monitoring Device Product Offerings
  • Table 66. DexCom Recent Development
  • Table 67. Medtronic Company Information
  • Table 68. Medtronic Introduction and Business Overview
  • Table 69. Medtronic Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medtronic Non-invasive Glucose Monitoring Device Product Offerings
  • Table 71. Medtronic Recent Development
  • Table 72. Senseonics Holdings Company Information
  • Table 73. Senseonics Holdings Introduction and Business Overview
  • Table 74. Senseonics Holdings Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Senseonics Holdings Non-invasive Glucose Monitoring Device Product Offerings
  • Table 76. Senseonics Holdings Recent Development
  • Table 77. Cnoga Medical Company Information
  • Table 78. Cnoga Medical Introduction and Business Overview
  • Table 79. Cnoga Medical Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Cnoga Medical Non-invasive Glucose Monitoring Device Product Offerings
  • Table 81. Cnoga Medical Recent Development
  • Table 82. Meiqi Medical Company Information
  • Table 83. Meiqi Medical Introduction and Business Overview
  • Table 84. Meiqi Medical Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Meiqi Medical Non-invasive Glucose Monitoring Device Product Offerings
  • Table 86. Meiqi Medical Recent Development
  • Table 87. Medtrum Technologies Company Information
  • Table 88. Medtrum Technologies Introduction and Business Overview
  • Table 89. Medtrum Technologies Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Medtrum Technologies Non-invasive Glucose Monitoring Device Product Offerings
  • Table 91. Medtrum Technologies Recent Development
  • Table 92. MicroTech Medical Company Information
  • Table 93. MicroTech Medical Introduction and Business Overview
  • Table 94. MicroTech Medical Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. MicroTech Medical Non-invasive Glucose Monitoring Device Product Offerings
  • Table 96. MicroTech Medical Recent Development
  • Table 97. POCTech Company Information
  • Table 98. POCTech Introduction and Business Overview
  • Table 99. POCTech Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. POCTech Non-invasive Glucose Monitoring Device Product Offerings
  • Table 101. POCTech Recent Development
  • Table 102. SIBIONICS Company Information
  • Table 103. SIBIONICS Introduction and Business Overview
  • Table 104. SIBIONICS Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. SIBIONICS Non-invasive Glucose Monitoring Device Product Offerings
  • Table 106. SIBIONICS Recent Development
  • Table 107. GHA Life Company Information
  • Table 108. GHA Life Introduction and Business Overview
  • Table 109. GHA Life Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. GHA Life Non-invasive Glucose Monitoring Device Product Offerings
  • Table 111. GHA Life Recent Development
  • Table 112. Infinovo Medical Company Information
  • Table 113. Infinovo Medical Introduction and Business Overview
  • Table 114. Infinovo Medical Non-invasive Glucose Monitoring Device Sales (), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Infinovo Medical Non-invasive Glucose Monitoring Device Product Offerings
  • Table 116. Infinovo Medical Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Non-invasive Glucose Monitoring Device Downstream Customers
  • Table 120. Non-invasive Glucose Monitoring Device Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Non-invasive Glucose Monitoring Device Product Picture
  • Figure 2. Global Non-invasive Glucose Monitoring Device Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Non-invasive Glucose Monitoring Device Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Non-invasive Glucose Monitoring Device Sales Volume (2020-2031) & ()
  • Figure 5. Global Non-invasive Glucose Monitoring Device Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Non-invasive Glucose Monitoring Device Report Years Considered
  • Figure 7. Global Non-invasive Glucose Monitoring Device Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Non-invasive Glucose Monitoring Device Players Sales Volume Ranking (2024) & ()
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-invasive Glucose Monitoring Device Revenue in 2024
  • Figure 10. Non-invasive Glucose Monitoring Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Wearable Devices Picture
  • Figure 12. Non-wearable Devices Picture
  • Figure 13. Global Non-invasive Glucose Monitoring Device Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Non-invasive Glucose Monitoring Device Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Non-invasive Glucose Monitoring Device Sales Volume by Type (2020 VS 2024 VS 2031) & ()
  • Figure 16. Global Non-invasive Glucose Monitoring Device Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Non-invasive Glucose Monitoring Device Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospital
  • Figure 19. Product Picture of Home Care
  • Figure 20. Product Picture of Other
  • Figure 21. Global Non-invasive Glucose Monitoring Device Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Non-invasive Glucose Monitoring Device Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Non-invasive Glucose Monitoring Device Sales Volume by Application (2020 VS 2024 VS 2031) & ()
  • Figure 24. Global Non-invasive Glucose Monitoring Device Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Non-invasive Glucose Monitoring Device Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Non-invasive Glucose Monitoring Device Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Non-invasive Glucose Monitoring Device Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Non-invasive Glucose Monitoring Device Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Non-invasive Glucose Monitoring Device Sales Volume (%), (2020-2031)
  • Figure 38. United States Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Non-invasive Glucose Monitoring Device Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Non-invasive Glucose Monitoring Device Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Non-invasive Glucose Monitoring Device Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Non-invasive Glucose Monitoring Device Industrial Chain
  • Figure 60. Non-invasive Glucose Monitoring Device Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!